Iterum Therapeutics (ITRM)
NASDAQ: ITRM
· Real-Time Price · USD
0.76
-0.07 (-8.52%)
At close: Aug 20, 2025, 3:40 PM
0.79
4.00%
After-hours: Aug 20, 2025, 04:10 PM EDT
Iterum Therapeutics Ratios and Metrics
Financials in USD. Fiscal
year is
January - December.
Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
PE Ratio | -1.53 | -2.14 | -1.32 | -0.9 | -0.91 | -0.89 | -0.53 | -0.67 | -0.28 | -0.32 | -0.55 | -0.17 | -1.36 | -5.04 | -4.65 | 6.81 | 14.46 | -0.47 |
PEG Ratio | -0.09 | 0.05 | 0.08 | n/a | 0.03 | 0.02 | -0.00 | 0.01 | -0.01 | -0.00 | 0.01 | -0.00 | -0.02 | 0.34 | 0.02 | -0.13 | -0.14 | -0.00 |
PS Ratio | n/a | n/a | n/a | n/a | n/a | n/a | 9.91 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
PB Ratio | -10.22 | -16.4 | -8.54 | -1.9 | -1.67 | -4.12 | -4.06 | 3.04 | 1.94 | 0.67 | 0.40 | 0.61 | 0.84 | 1.45 | 1.55 | 1.94 | 9.56 | 5.90 |
P/FCF Ratio | -8.36 | -13.68 | -8.19 | -8.18 | -2.69 | -1.93 | -2.08 | -1.13 | -1.81 | -1.32 | -2.6 | -4.36 | -5.85 | -20.7 | -31.44 | -25.76 | -54.07 | -164.21 |
P/OCF Ratio | -8.36 | -13.69 | -8.19 | -8.18 | -2.69 | -1.93 | -2.08 | -1.13 | -1.81 | -1.32 | -2.63 | -4.37 | -5.85 | -20.7 | -31.6 | -26.08 | -54.07 | -164.21 |
OCF/S Ratio | n/a | n/a | n/a | n/a | n/a | n/a | -4.75 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Debt / Equity Ratio | -8.38 | -12.54 | -11.16 | -1.95 | -1.98 | -3.34 | -3.05 | 5.71 | 4.48 | 1.59 | 1.02 | 0.93 | 0.54 | 0.45 | 0.50 | 0.53 | 0.54 | 1.32 |
Quick Ratio | 2.52 | 3.58 | 1.41 | 0.85 | 0.77 | 1.07 | 1.89 | 2.35 | 4.41 | 7.00 | 319.84 | 8.88 | 9.47 | 7.58 | 13.63 | 5.06 | 2.80 | 2.38 |
Current Ratio | 2.69 | 3.72 | 1.41 | 0.85 | 0.77 | 1.07 | 1.89 | 2.35 | 4.40 | 6.96 | 310.40 | 8.88 | 9.47 | 7.58 | 13.43 | 5.06 | 2.80 | 2.38 |
Asset Turnover | n/a | n/a | n/a | n/a | n/a | n/a | 0.10 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Interest Coverage | -12.31 | -6.95 | 0.88 | -8.28 | -6.96 | -12.66 | -28.22 | -55.62 | -33.4 | -21.38 | n/a | -11.06 | -10.51 | -7.1 | -8.85 | -5.74 | -7.13 | -1.98 |
Return on Equity | 1.67 | 1.92 | 1.61 | 0.53 | 0.46 | 1.15 | 1.93 | -1.13 | -1.72 | -0.52 | -0.18 | -0.89 | -0.15 | -0.07 | -0.08 | 0.07 | 0.17 | -3.14 |
Return on Assets | -0.19 | -0.15 | -0.15 | -0.38 | -0.35 | -0.36 | -0.47 | -0.1 | -0.24 | -0.17 | -0.08 | -0.41 | -0.09 | -0.04 | -0.05 | 0.04 | 0.07 | -0.86 |
Return on Invested Capital | -0.19 | -0.13 | -0.09 | -0.46 | -0.37 | -0.43 | -0.91 | -0.74 | -0.27 | -0.17 | -0.12 | -0.11 | -0.12 | -0.11 | -0.08 | -0.05 | -0.09 | -0.08 |
Dividend Yield | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Payout Ratio | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Gross Profit Margin | n/a | n/a | n/a | n/a | n/a | n/a | -0.17 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Net Profit Margin | n/a | n/a | n/a | n/a | n/a | n/a | -4.72 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Pretax Profit Margin | n/a | n/a | n/a | n/a | n/a | n/a | -4.66 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Profit Margin | n/a | n/a | n/a | n/a | n/a | n/a | -4.36 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
FCF Margin | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
EBITDA Margin | n/a | n/a | n/a | n/a | n/a | n/a | -4.34 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |